Moexipril Hydrochloride

Hypertensive disease

Treatment

1 FDA approval

20 Active Studies for Moexipril Hydrochloride

What is Moexipril Hydrochloride

Moexipril

The Generic name of this drug

Treatment Summary

Hydrochlorothiazide is a type of medication used to treat edema, or swelling, and high blood pressure. It is the most commonly prescribed thiazide diuretic, but is being used less often in favor of other medications such as angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. This drug has been approved by the FDA since 1959 and is often combined with other medications for more effective treatment.

Univasc

is the brand name

image of different drug pills on a surface

Moexipril Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Univasc

Moexipril

1995

42

Approved as Treatment by the FDA

Moexipril, commonly known as Univasc, is approved by the FDA for 1 uses like Hypertensive disease .

Hypertensive disease

Used to treat High Blood Pressure (Hypertension) in combination with Hydrochlorothiazide

Effectiveness

How Moexipril Hydrochloride Affects Patients

Hydrochlorothiazide helps the body get rid of extra water by preventing the kidneys from reabsorbing water from the urine. The amount taken will vary from person to person, usually ranging from 25-100mg. People with reduced kidney or liver function should be careful when taking this drug.

How Moexipril Hydrochloride works in the body

Hydrochlorothiazide helps your body remove sodium and water. It is transported from the bloodstream into cells in your kidneys. Sodium is normally absorbed by these cells and pumped into the area around them, creating an imbalance that helps the body absorb more water. Hydrochlorothiazide acts on this area of the kidneys and prevents sodium from being absorbed, so the body absorbs less water.

When to interrupt dosage

The prescribed amount of Moexipril Hydrochloride is contingent upon the diagnosed condition, including Antepartum magnesium sulfate prophylaxis, inadequately regulated blood pressure with monotherapy and antihypertensives. The dose of dosage is contingent upon the approach of administration (e.g. Tablet, coated - Oral or Oral) provided in the table below.

Condition

Dosage

Administration

Hypertensive disease

, 7.5 mg, 15.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Tablet, coated - Oral, Tablet, coated

Warnings

Moexipril Hydrochloride has two contraindications and should not be blended with any of the conditions outlined in the below table.

Moexipril Hydrochloride Contraindications

Condition

Risk Level

Notes

Angioedema

Do Not Combine

Type 2 Diabetes

Do Not Combine

Pulse Frequency

Do Not Combine

Anuria

Do Not Combine

There are 20 known major drug interactions with Moexipril Hydrochloride.

Common Moexipril Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

Amifostine

Major

Moexipril may increase the hypotensive activities of Amifostine.

Azathioprine

Major

The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Moexipril is combined with Azathioprine.

Hydroxyzine

Major

The risk or severity of QTc prolongation can be increased when Moexipril is combined with Hydroxyzine.

Lithium carbonate

Major

The serum concentration of Lithium carbonate can be increased when it is combined with Moexipril.

Lithium citrate

Major

The serum concentration of Lithium citrate can be increased when it is combined with Moexipril.

Moexipril Hydrochloride Toxicity & Overdose Risk

The toxic dose of hydrochlorothiazide in mice and rats is greater than 10g/kg. Symptoms of overdose may include low levels of potassium, chlorine, or sodium in the blood. Treatment for overdose will involve providing fluids and electrolytes, and oxygen may be given if breathing is affected. To treat low blood pressure, the patient may receive vasopressors.

image of a doctor in a lab doing drug, clinical research

Moexipril Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Moexipril Hydrochloride?

158 active clinical trials are assessing the potential of Moexipril Hydrochloride to ameliorate Cirrhosis, Edema, and Congestive Heart Failure.

Condition

Clinical Trials

Trial Phases

Hypertensive disease

41 Actively Recruiting

Not Applicable, Phase 3, Phase 1, Phase 2

Moexipril Hydrochloride Reviews: What are patients saying about Moexipril Hydrochloride?

5

Patient Review

7/2/2008

Moexipril Hydrochloride for High Blood Pressure

I've been taking this for years with no issues, but about four months ago my blood pressure started going up again. I'm still on the medication, plus atenolol. So far it's not been too bad.

5

Patient Review

1/20/2013

Moexipril Hydrochloride for High Blood Pressure

I had no problems with this medication, but my doctor wants to remove the diuretic. The pharmacy claims that no one cares about that medicine anymore. Are there any possible substitutes?

3.7

Patient Review

2/16/2010

Moexipril Hydrochloride for High Blood Pressure

My blood pressure has been higher in the evening since taking this drug, which is not ideal.

3

Patient Review

3/16/2010

Moexipril Hydrochloride for Osteoporosis

This treatment is okay. I'm not a huge fan of drugs, but this one helped me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about moexipril hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When should moexipril be taken?

"Moexipril is a drug typically taken once or twice daily, on an empty stomach and either one hour before or two hours after a meal. It is recommended that users take the drug at the same time(s) each day in order to help with remembering to take the medication."

Answered by AI

What is the brand name for moexipril?

"Univasc is a Brand name for the drug Ranolazine and is manufactured by Par Pharmaceutical.

The brand name for the drug Ranolazine is Univasc, and it is manufactured by Par Pharmaceutical."

Answered by AI

Why was moexipril discontinued?

"Product number 2691 has been discontinued and is no longer for sale."

Answered by AI

What is moexipril used for?

"Moexipril is used to treat high blood pressure. High blood pressure can strain the heart and arteries, and if left untreated, can cause long-term damage to the heart and arteries."

Answered by AI

Clinical Trials for Moexipril Hydrochloride

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Barber and Pharmacist Coordination for High Blood Pressure

35 - 79
Male
Los Angeles, CA

The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Christine Albert, MD, MPH

Image of Foothills Medical Center in Calgary, Canada.

Spinal Cord Stimulation for High Blood Pressure

18+
All Sexes
Calgary, Canada

High blood pressure, also called hypertension, raises the risk of heart disease, stroke, and kidney disease. Medications work well for many people, but some people still have blood pressure that stays too high, or they have side effects from their medications. Researchers are looking for treatments that do not involve taking more medication. Nerves help control blood pressure by changing how blood vessels tighten and how hard the heart pumps. Because of this, treatments that act on nerves may be able to lower blood pressure. Spinal cord stimulation is a treatment already used to manage long-term pain. It uses a small device, placed under the skin during a standard operation, that sends mild electrical signals to the spine. Laboratory studies suggest that stimulating the lower part of the mid-back may also lower blood pressure, but this has not been carefully studied in people who already use these devices. This study will look at whether changing the settings on a spinal cord stimulator affects blood pressure. About 11 adults who have high blood pressure and who already have a spinal cord stimulator for long-term pain. No new device will be placed, and no surgery or other invasive procedure will be done for this study. Participants attend a series of study visits. At each visit, trained staff record blood pressure and heart rate while the stimulator is turned on, turned off, and set to other settings that the person's care team has approved and that the person finds comfortable. There are rest breaks between each setting. Over successive visits, the study team works to identify the settings that best lower blood pressure. Participants can stop at any time, and their usual settings are restored at the end of each visit. The study will also look at whether this kind of testing is practical and comfortable for participants. The results will help researchers decide whether larger studies of spinal cord stimulation for blood pressure control are worth doing.

Waitlist Available
Has No Placebo

Foothills Medical Center

Aaron Phillips, PhD

Image of Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington in Arlington, United States.

Alcohol Abstinence for High Blood Pressure

26 - 49
All Sexes
Arlington, TX

The purpose of this study is to learn whether avoiding alcohol can improve heart and blood vessel health in adults who regularly drink alcohol and have high blood pressure. High blood pressure is a major risk factor for cardiovascular disease (CVD), including heart attack and stroke. In this randomized, controlled trial, men and women aged 26 to 49 years who regularly consume alcohol and have high blood pressure will be assigned by chance to either stop drinking alcohol or continue their usual drinking habits for 8 weeks. Researchers will compare changes in blood pressure and other cardiovascular disease risk factors between the two groups. The information gained from this study may help researchers and health care providers better understand the effects of alcohol consumption on cardiovascular health and whether alcohol abstinence can reduce heart disease risk, especially in adults with high blood pressure.

Recruiting
Has No Placebo

Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington

Image of Department of Family & Community Medicine; University of Alabama at Birmingham in Birmingham, United States.

Treatment for High Blood Pressure

18+
All Sexes
Birmingham, AL

The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.

Waitlist Available
Has No Placebo

Department of Family & Community Medicine; University of Alabama at Birmingham

Have you considered Moexipril Hydrochloride clinical trials?

We made a collection of clinical trials featuring Moexipril Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of NeuroFit Lab, Ivor Wynne Centre, McMaster University in Hamilton, Canada.

Isometric Handgrip Exercise for High Blood Pressure

65+
All Sexes
Hamilton, Canada

The goal of this clinical trial is to evaluate whether a short, supervised isometric handgrip exercise program is feasible and acceptable for older adults with elevated blood pressure or hypertension. It will also explore whether this type of exercise may improve blood pressure and cognitive function. The main questions it aims to answer are: * Is this handgrip exercise program practical and acceptable for older adults to participate in within a community exercise setting? * Does participation in the program lead to changes in blood pressure and cognitive function? Researchers will compare two handgrip devices to determine whether the method of delivering the exercise influences feasibility and outcomes. Participants will: * Be randomly assigned to use one of two handgrip devices. * Complete supervised exercise sessions twice per week for 4 weeks. * Perform brief handgrip contractions at a set intensity during each session. * Complete blood pressure and cognitive assessments before and after the program.

Recruiting
Has No Placebo

NeuroFit Lab, Ivor Wynne Centre, McMaster University (+1 Sites)

Jennifer Heisz, PhD

Image of Vanderbilt University Medical Center in Nashville, United States.

2-HOBA for Salt Sensitivity of Blood Pressure

18+
All Sexes
Nashville, TN

Hypertension is the leading cause of preventable deaths globally, driven by complications such as myocardial infarction, stroke, heart failure, and kidney disease. Recent updates in hypertension classification by the American Heart Association (AHA) place nearly half of the U.S. population in the hypertensive category. Excess dietary salt is a major risk factor for hypertension, with 50% of hypertensive individuals exhibiting salt-sensitivity of blood pressure (SSBP). SSBP is an independent predictor of cardiovascular events and death. While kidney mechanisms in salt-sensing have been extensively studied, emerging evidence suggests that immune cells can also sense sodium (Na+). This trial hypothesizes that myeloid cell-derived isolevuglandins (IsoLGs) drive endothelial dysfunction, perpetuating the salt-sensitive phenotype. Preliminary data indicate that targeting IsoLGs with the IsoLG scavenger 2-hydroxybenzylamine (2-HOBA) may interrupt this immune-vascular axis, reducing salt sensitivity and associated cardiovascular risks. This phase 2 clinical trial aims to investigate the role of 2-HOBA in modulating immune cell function within blood vessels in hypertensive patients. The study will explore the impact of immunity on salt sensitivity and assess 2-HOBA's potential to reduce endothelial dysfunction, improve immune cell activation, and alleviate SSBP.

Phase 2
Waitlist Available

Vanderbilt University Medical Center

Image of UPMC Magee Womens Hospital in Pittsburgh, United States.

Mobile Health Program for High Blood Pressure After Preeclampsia

18+
Female
Pittsburgh, PA

Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.

Recruiting
Has No Placebo

UPMC Magee Womens Hospital

Malamo Countouris, MD, MS

Have you considered Moexipril Hydrochloride clinical trials?

We made a collection of clinical trials featuring Moexipril Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Hāmākua-Kohala Health Center in Honokaa, United States.

Produce Prescription for High Blood Pressure

18+
All Sexes
Honokaa, HI

This multi-site randomized controlled trial uses a community-based approach to evaluate a Food as Medicine program for Native Hawaiian and Pacific Islander (NHPI) adults in Hawaii who have high blood pressure and difficulty affording healthy food. The study has two main goals: (1) to implement a produce prescription program and see if adding personal support from Community Health Workers (CHW) improves blood pressure among other health outcomes, and (2) to determine the program's cost-effectiveness. The study will take place across three Federally Qualified Health Centers in Hawaii. Produce prescription program participants at each site will receive $100 per month, either in the form of produce boxes or monthly vouchers to purchase fruits and vegetables, for 12 months (totaling $1200). In past studies, personal challenges (e.g., lack of transportation, lack of cooking skills) have made it difficult for participants to use the vouchers and/or the purchased produce. In other food as medicine interventions, participants have similarly faced various personal, social, and environmental barriers that limit the program's efficacy. To help participants navigate through these challenges, the investigators want to test adding 1-on-1 support from a CHW throughout the program. Other studies have found that health interventions delivered by CHWs have been effective in reducing blood pressure, blood glucose and weight, especially among vulnerable populations, such as NHPIs and those with food insecurity. The CHWs in this study will receive a training using a curriculum tailored specifically to their community and that is in alignment with the Pilinahā: The Four Connections Framework, which focuses on key connections that Indigenous people seek to attain health and can be employed to overcome health disparities. To test the effectiveness of the added CHW support, there will be two groups of participants: Group 1 (Intervention) will receive the monthly produce prescription ($100 vouchers or produce box) plus meet with a CHW every two months for support with program challenges. Group 2 (Control) will receive the same monthly produce prescription, but will not have meetings with a CHW. The investigators want to see if the added support from CHWs leads to better blood pressure results, among other health outcomes. Upon providing informed consent and enrolling into the program, produce prescription program participants will: * Attend 5 study visits over the one year program. These happen at the start, and then at 3, 6, 9, and 12 months. * Complete health checks at the first visit. This includes getting a home blood pressure monitor and learning about heart health and nutrition. Staff will measure height, weight, waist size, and blood pressure. * Answer surveys about their demographic background, health habits, diet, and culture. * Receive $100 in vouchers every month for 12 months to redeem for fruits and vegetables at a local retailer. * Group 1 will additionally meet with a CHW every two months for 1-on-1 support with any challenges related to the program. * Group 2 will receive monthly reminders to use their vouchers but no CHW meetings. After the program ends, researchers will analyze the financial value of the intervention. This involves calculating the total cost to run the program (including vouchers, CHW training and salaries, and administrative costs) and comparing it to potential savings in healthcare costs. By looking at improvements in blood pressure, researchers can estimate how many heart-related health problems were prevented and how much money was saved on medical care.

Waitlist Available
Has No Placebo

Hāmākua-Kohala Health Center (+2 Sites)

Have you considered Moexipril Hydrochloride clinical trials?

We made a collection of clinical trials featuring Moexipril Hydrochloride, we think they might fit your search criteria.
Go to Trials